Author Topic: Low-dose rapamycin shows promise for enhancing healthspan in older adults  (Read 29 times)

Ketua Dobbs

  • Administrator
  • Rank: Jr. Consultant
  • *****
  • Posts: 703
  • Ketua
    • DOBBS
  • Field of Practice: CLINICAL HAEMATOLOGY
  • State: Selangor
Low-dose rapamycin shows promise for enhancing healthspan in older adults

A new research paper was published in Aging (Aging-US) Volume 17, Issue 4, on April 4, 2025, titled "Influence of rapamycin on safety and healthspan metrics after one year: PEARL trial results."
Source: Low-dose rapamycin shows promise for enhancing healthspan in older adults
Let's make Bulletin Boards great again

Doctors Only Bulletin Board System (DOBBS)


 


Powered by EzPortal